BofA analyst Matthew DeYoe upgraded Chemours to Buy from Neutral with a price target of $40, up from $37.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CC:
BofA analyst Matthew DeYoe upgraded Chemours to Buy from Neutral with a price target of $40, up from $37.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CC: